ClinicalTrials.govpublic full text
A Safety Study of Contralateral Eye Dosing of VGR-R01 in Participants With Bietti's Crystalline Dystrophy (BCD)
bietti crystalline dystrophy, vgr-r01, cyp4v2, gene therapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858350
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.